Literature DB >> 2165014

Muscular dysgenesis in mice: a model system for studying excitation-contraction coupling.

B A Adams1, K G Beam.   

Abstract

Muscular dysgenesis (mdg) is a lethal autosomal, recessive mutation of mice. Skeletal muscle from dysgenic mice is paralyzed due to the failure of excitation-contraction (E-C) coupling. Considerable evidence indicates that this failure results from the absence of a specific gene product, the alpha 1 subunit of the skeletal muscle receptor for dihydropyridine calcium channel modifiers. This dihydropyridine receptor is hypothesized to function in E-C coupling of normal skeletal muscle as the voltage sensor that triggers calcium release from the sarcoplasmic reticulum and thereby causes contraction. The skeletal muscle dihydropyridine receptor is also postulated to function as the ion channel responsible for a slowly activating, dihydropyridine-sensitive calcium current (Islow). Dysgenic skeletal muscle lacks Islow but expresses, at low levels, a distinctly different dihydropyridine-sensitive calcium current (Idys). The channel protein underlying Idys is incapable of serving as a voltage sensor for E-C coupling. Studies using dysgenic skeletal muscle have provided significant insight into the role of dihydropyridine receptors in E-C coupling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165014     DOI: 10.1096/fasebj.4.10.2165014

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Progressive predominance of 'skeletal' versus 'cardiac' types of excitation-contraction coupling during in vitro skeletal myogenesis.

Authors:  C Cognard; M Rivet-Bastide; B Constantin; G Raymond
Journal:  Pflugers Arch       Date:  1992-11       Impact factor: 3.657

Review 2.  Functional roles of the gamma subunit of the skeletal muscle DHP-receptor.

Authors:  Werner Melzer; Zoita Andronache; Daniel Ursu
Journal:  J Muscle Res Cell Motil       Date:  2006-08-09       Impact factor: 2.698

3.  Ca2+/CaM-dependent inactivation of the skeletal muscle L-type Ca2+ channel (Cav1.1).

Authors:  Katarina Stroffekova
Journal:  Pflugers Arch       Date:  2007-09-26       Impact factor: 3.657

Review 4.  Sparks and embers of skeletal muscle: the exciting events of contractile activation.

Authors:  László Csernoch
Journal:  Pflugers Arch       Date:  2007-03-07       Impact factor: 3.657

5.  Local calcium signals induced by hyper-osmotic stress in mammalian skeletal muscle cells.

Authors:  Simona Apostol; Daniel Ursu; Frank Lehmann-Horn; Werner Melzer
Journal:  J Muscle Res Cell Motil       Date:  2009-05-13       Impact factor: 2.698

6.  Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle.

Authors:  Joanne T Hulme; Keiichi Konoki; Teddy W-C Lin; Marina A Gritsenko; David G Camp; Diana J Bigelow; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

7.  Voltage-dependent potentiation of L-type Ca2+ channels in skeletal muscle cells requires anchored cAMP-dependent protein kinase.

Authors:  B D Johnson; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

8.  Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres.

Authors:  Marino DiFranco; Philip Tran; Marbella Quiñonez; Julio L Vergara
Journal:  J Physiol       Date:  2011-01-24       Impact factor: 5.182

9.  Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.

Authors:  H Nakayama; M Taki; J Striessnig; H Glossmann; W A Catterall; Y Kanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  Voltage-dependent calcium and potassium conductances in striated muscle fibers from the scorpion, Centruroides sculpturatus.

Authors:  W F Gilly; T Scheuer
Journal:  J Membr Biol       Date:  1993-06       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.